522 Prevalence of TP53 germ-line mutations in patients with early-onset breast cancer and different types of family history
Saura, C, Gutiérrez-Enríquez, S, Masas, M, Tenés, A, Gadea, N, Fortuny, D, Ferro, J.I, Balmaña, J, Diez, O
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
A multi-centre international quality control study comparing mRNA splicing assay protocols and reporting practices from the ENIGMA consortium
Whiley, P, Walker, LC, De LA Hoya, M, Wappenschmidt, B, Becker, A, Blanco, A, Blok, MJ, Caligo, MA, Chatfield, C, Couch, F, Diez, O, Fachal, L, Guidugli, L, Enríquez, S, Hansen, T, Houdayer, C, Imrie, S, Lafferty, A, Lázaro, C, Menéndez, M, Montagna, M, Montalbán, G, Santamariña, M, Pederson, I, Southey, M, Tancredi, M, Tenès, A, Thomassen, M, Van Overeem Vega, A, Spurdle, AB, Brown, MA
Published in Hereditary cancer in clinical practice (01.01.2012)
Published in Hereditary cancer in clinical practice (01.01.2012)
Get full text
Journal Article
High prevalence of BRCA1/2 germline mutations in female breast cancer patients with triple-negative phenotype (TNBC) and family history
Saura, C., Sáanchez-Ollé, G., Bosch, N., Gadea, N., Masas, M., Tenes, A., Gutierrez-Enríquez, S., Díez, O., Baselga, J., Balmañna, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article